The number of males, etiology, and doses of pregabalin and gabapentin are displayed in Table 1. In conclusion, pregabalin demonstrated superior and faster efficacy in alleviating neuropathic pain than gabapentin did. Additionally, it improved patient-reported outcomes, resulted in lower opioid consumption, and led to fewer adverse events. The pregabalin market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America dominated the global pregabalin market in terms of revenue in 2022, driven by its advanced healthcare infrastructure, substantial investments in R and D, and the presence of major industry players offering pregabalin. On the other hand, Asia-Pacific is expected to register the fastest CAGR during the forecast period.
SAFETY
Although this meta-analysis compared the mentioned outcomes, there were variables that could not be included in the meta-analysis but were reported in individual studies. For instance, Solak et al. (65) observed that pregabalin improved pruritus to a greater extent than gabapentin in patients with uremic pruritus in hemodialysis patients with documented peripheral neuropathy. Pérez et al. found that pregabalin reduced symptoms pregabalin for sale uk of depression and anxiety in patients with peripheral neuropathy, although no significant differences were found (11). However, Ozgencil demonstrated a significant reduction in anxiety in patients treated with pregabalin (18). Ozgenzil et al. (18) also found a higher percentage of patient satisfaction in the pregabalin group compared to gabapentin.
- In the third study (E3), the same total daily dose was divided into two equal doses for one group (twice a day dosing) and three equal doses for another group (three times a day dosing).
- The major factor that drives the pregabalin market growth is an increase in the number of cases of epilepsy, neuropathic pain, and anxiety disorder.
- If you take the liquid form of pregabalin, use an accurate measuring device to measure your dose.
- Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Major Depressive Disorder – 5EU Drug Forecast and Market Assessment…
The manufacturer of a brand-name drug can sell the drug exclusively for up to 20 years. And because generics have the same active ingredients as brand-name drugs, they don’t need to be studied again. As of August 9, Lyrica still had about 43% of the market for pregabalin, but that’s likely to change as patients, doctors and insurers became more aware of the significant difference in price.
